Can-Fite BioPharma Ltd.
CANF
$0.53
-$0.04-6.81%
AMEX
06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 36.55% | 36.55% | -11.60% | -50.83% | -20.86% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 6.18% | 6.18% | 12.11% | -14.93% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -1.28% | -- | -- |
Total Current Assets | 30.82% | 30.82% | -9.35% | -46.58% | -13.19% |
|
|||||
Total Current Assets | 30.82% | 30.82% | -9.35% | -46.58% | -13.19% |
Net Property, Plant & Equipment | 2.13% | 2.13% | 70.37% | -23.58% | -14.55% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 30.36% | 30.36% | -8.70% | -46.32% | -13.20% |
|
|||||
Total Accounts Payable | 30.17% | 30.17% | 44.73% | 9.26% | 82.63% |
Total Accrued Expenses | 17.67% | 17.67% | 3.39% | -27.85% | 50.16% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 58.33% | 58.33% | 96.30% | -18.18% | 20.00% |
Total Finance Division Other Current Liabilities | -36.32% | -36.32% | -34.89% | -18.77% | -18.36% |
Total Other Current Liabilities | -36.32% | -36.32% | -34.89% | -18.77% | -18.36% |
Total Current Liabilities | 6.69% | 6.69% | 1.58% | -11.02% | 29.87% |
|
|||||
Total Current Liabilities | 6.69% | 6.69% | 1.58% | -11.02% | 29.87% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 57.14% | 57.14% | 292.31% | -4.55% | -58.06% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -3.62% | -3.62% | -7.71% | -24.59% | -20.52% |
Total Liabilities | 2.70% | 2.70% | -1.66% | -17.20% | -0.51% |
|
|||||
Common Stock & APIC | 6.41% | 6.41% | 4.32% | 1.85% | 8.41% |
Retained Earnings | -5.42% | -5.42% | -4.97% | -4.75% | -10.35% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | 68.78% | 68.78% | -12.93% | -63.94% | -20.42% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 68.78% | 68.78% | -12.93% | -63.94% | -20.42% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 68.78% | 68.78% | -12.93% | -63.94% | -20.42% |
|